Reversal of an abnormality of polymorphonuclear leukocyte chemotaxis with lithium.
D000328:Adult; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D000242:Cyclic AMP / Q000378:metabolism / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D008094:Lithium / Q000494:pharmacology* / Q000627:therapeutic use; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013481:Superoxides / Q000096:biosynthesis; D015054:Zymosan / Q000494:pharmacology
D013481:Superoxides; D015054:Zymosan; D008094:Lithium; D000242:Cyclic AMP; D004837:Epinephrine